First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer TherapyMalabika Sen, Jennifer R. Grandis, Robert L. Ferris et al.|Cancer Discovery|2012Cited by 313
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival BenefitMarco A. Mascarella, Umamaheswar Duvvuri, Tolani F. Olonisakin et al.|Clinical Cancer Research|2023Cited by 10